US20210130450A1

Egfl6 specific monoclonal antibodies and methods of their use

University of Texas System

Abstract

Isolated or recombinant anti-EGFL6 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.

University: University of Texas System
Assignee: The Board Of Regents Of The University Of Texas System
Inventor: Ningyan Zhang
Priority date: February 05, 2016
Filing date: November 12, 2020
Publication date: May 06, 2021
Language: en
PDF source: https://patentimages.storage.googleapis.com/03/55/4b/65f6551634d3c0/US20210130450A1.pdf
Metadata fetched: August 29, 2026 00:28